Institutional investors hold a majority ownership of DEPO through the 78.75% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended June 2014, these large investors purchased a net $2.4 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HAYS ADVISORY LLC Bought 512.8 Thousand shares of Depomed Inc